Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Zydus Lifesciences Ltd. (ZYDUSLIFE)
Market Closed
10 Aug, 10:00
XNSE
All
(2)
IN
(2)
XNSE
Primary
MSE
₹
1,119.
00
+4.8
+0.4308%
₹
909.63B
Market Cap
31.93
P/E Ratio
44%
Div Yield
932,246
Volume
0
Eps
₹
1,114.2
Previous Close
Watching
Watch
Add Transaction
Day Range
1,112.5
1,124.9
Year Range
835.5
1,181.5
Want to track
ZYDUSLIFE
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Zydus Lifesciences Ltd. (ZYDUSLIFE) Statistics
Valuation metrics
Market Cap
909.63B
Enterprise value
1.22T
Trailing P/E (ttm)
22.24
Forward P/E
21.76
PEG ratio
1.95
Price/Sales (ttm)
4.09
Price/Book (mrq)
4.13
Enterprise Value/Revenue
4.5
Enterprise Value/EBITDA
14.84
Overview
Shares outstanding
1.01B
Float
249.47M
Shares short
-
% Held by insiders
0.75%
% Held by institutions
0.15%
Average volume (10 days)
929.43K
Average volume (90 days)
1.52M
Price summary
52-Week low
835.5
52-Week high
1,181.5
Beta
0.37
50-Day moving average
1,123.93
200-Day moving average
992.62
Dividends and splits
Forward annual dividend rate
44
Forward annual dividend yield
0.0491%
Trailing annual dividend rate
1
Trailing annual dividend yield
0.0009%
5-Year annual dividend yield
0.83%
Payout ratio
0.22
Dividend Date
14 Aug 2025
Ex-Dividend Date
25 Jul 2025
Last split factor
5:1
Last split Date
6 Oct 2015
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.19%
Operating margin
0.29%
Operational effectiveness
Return on assets
0.1%
Return on equity
0.19%
Income Statement
Revenue (ttm)
260.89B
Revenue per share (ttm)
269.88
Quarterly revenue growth (yoy)
0.3%
Gross profit (ttm)
188.76B
EBITDA
76.07B
Net income to common (ttm)
49.38B
Diluted EPS (ttm)
50.1
Quarterly earnings growth (yoy)
0.02%
Balance Sheet
Total cash (mrq)
70.68B
Total cash per share (mrq)
71.5
Total debt (mrq)
96.36B
Total Debt/Equity (mrq)
0.46
Current ratio (mrq)
1.27%
Book value per share (mrq)
294.08
Cash Flow
Cash flow statement
76.54B
Levered free cash flow (LFCF)
45.26B